___

• 1. Muthugovindan D, Hartman L A. Pediatric epilepsy syndromes. The Neurologist 2010; 4: 223-37.
• 2. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsy and epileptic syndromes. Epilepsia 1989; 30: 389-99.
• 3. Wolf P. Basic principles of the ILAE syndrome classification. Epilepsy Res 2006; 70: 20-6.
• 4. Dehan M, Quillerou D, Navelet Y, et al. Convulsions in the fifth day of life: a new syndrome? Arch Fr Pediatr 1977; 34: 730-42.
• 5. Pryor DS, Don N, Macourt DC. Fifth day fits: a syndrome of neonatal convulsions. Arch Dis Child 1981; 56: 753-8.
• 6. Goldberg HJ, Sheehy EM. Fifth day fits: an acute zinc deficiency syndrome? Arch Dis Child 1982; 8: 633-5.
• 7. Miles DK, Holmes GL. Benign neonatal seizures. J Clin Neurophysiol 1990; 7: 369-79.
• 8. Hirsch E, Velez A, Shellal F, et al. Electroclinical sign of benign neonatal familial convulsions. Ann Neurol 1993; 34: 835-41.
• 9. Ronen GM, Rosales TO, Connolly M, et al. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993; 43: 1355-60.
• 10. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18: 25-9.
• 11. Singh NA, Otto JF, Dahle EJ, et al. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol 2008; 586: 3405-23.
• 12. Ohtahara S, Yamatogi Y. Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol 2003; 20: 398-407.
• 13. Yamatogi Y, Ohtahara S. Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases. Brain Dev 2002; 24: 13-23.
• 14. Miller SP, Dilenge ME, Meagher-Villemure K, et al. Infantile epileptic encephalopathy (Ohtahara syndrome) and migrational disorder. Pediatr Neurol. 1998; 19: 50-4
• 15. Dulac O. Epileptic encephalopathy. Epilepsia 2001; 3: 23-6.
• 16. Komaki H, Sugai K, Maehara T, et al. Surgical treatment of early-infantile epileptic encephalopathy with suppression-bursts associated with focal cortical dysplasia. Brain Dev 2001; 23: 727-31.
• 17. Ohtahara S, Yamatogi Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res 2006; 1: 58-67.
• 18. Djukic A, Lado FA, Shinnar S, et al. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other? Epilepsy Res 2006; 1: 68-76.
• 19. Dalla Bernardina B, Dulac O, Fejerman N, et al. Early myoclonic epileptic encephalopathy (EMEE). Eur J Pediatr 1983; 140: 248-52.
• 20. Murakami N, Ohtsuka Y Ohtahara S. Early infantile epileptic syndromes with suppression-bursts: early myoclonic encephalopathy vs. Ohtahara syndrome. Jpn J Psychiatry Neurol 1993; 47: 197-200.
• 21. Wirrell E, Farrell K, Whiting S. The epileptic encephalopathies of infancy and childhood. Can J Neurol Sci 2005; 32: 409-18.
• 22. Cowan LD. The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 2002; 8: 171-81.
• 23. Hrachovy RA, Frost JD. Infantile epileptic encephalopathy with hypsarrhytmia (infantile spasms /West syndrome). J Clin Neurophysiol 2003; 6: 408-25.
• 24. Ohtsuka Y, Kobayashi K, Ogino T, Oka E. Spasms in clusters in epilepsies other than typical West syndrome. Brain Dev 2001; 23: 473-81.
• 25. Gaily E, Liukkonen E, Paetau R, et al. Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Dev Med Child Neurol 2001; 10: 658-67.
• 26. Guzzetta F. Cognitive and behavioral outcome in West syndrome. Epilepsia 2006; 2: 49-52.
• 27. Appleton RE. West syndrome: long-term prognosis and social aspects. Brain Dev 2001; 23: 688-91.
• 28. Overby PJ, Kossoff EH. Treatment of infantile spasms. Curr Treat Options Neurol 2006; 8: 457-64.
• 29. Hancock E, Osborne JP. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999; 14: 71-4.
• 30. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2008; 8: CD001770.
• 31. Kossoff EH, Hedderick EF, Turner Z, et al. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008; 49: 1504-09.
• 32. Auvin S, Pandit F, De Bellecize J, et al. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients. Epilepsia 2006; 47: 387-93.
• 33. Dravet C, Bureau M, Genton P. Benign myoclonic epilepsy of infancy: electroclinical symptomatology and differential diagnosis from the other types of generalized epilepsy of infancy. Epilepsy Res Suppl 1992; 6: 131-5.
• 34. Darra F, Fiorini E, Zoccante L, et al. Benign myoclonic epilepsy in infancy (BMEI): a longitudinal electroclinical study of 22 cases. Epilepsia 2006; 5: 31-5.
• 35. Dravet C, Bureau M. Benign myoclonic epilepsy in infancy. Adv Neurol. 2005; 95: 127-37.
• 36. Vigevano F, Fusco L, Di Capua M, et al. Bening infantile familial convulsions. Euro J Pediatrrics 1992; 151: 608-12.
• 37. Vigevano F. Bening familial infantile seizures. Brain Dev 2005; 27: 172-7.
• 38. Okumura A, Watanabe K, Negoro T, et al. Ictal EEG in benign partial epilepsy in infancy. Pediatr Neurol 2007; 36: 8-12.
• 39. Watanabe K, Okumura A. Bening partial epilepsies in infancy. Brain Dev 2000; 22: 296-300.
• 40. Okumura A, Watanabe K, Negoro T, et al. Long-term follow-up of patients with benign partial epilepsy in infancy. Epilepsia 2006; 47: 181-5.
• 41. Dravet C, Bureau M, Oguni H, et al. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005; 95: 71-102.
• 42. Ohmori I, Ouchida M, Ohtsuka Y, et al. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun 2002; 295: 17-23.
• 43. Singh R, Andermann E, Whitehouse WP, et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+? Epilepsia 2001; 42: 837-44.
• 44. Millichap JJ, Koh S, Laux LC, et al. Child Neurology: Dravet syndrome: when to suspect the diagnosis. Neurology. 2009; 13: e59-62
• 45. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000; 356: 1638-42.
• 46. Caraballo RH, Cersosimo RO, Sakr D, et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005; 46: 1539-44.
• 47. Ragona F, Brazzo D, De Giorgi I, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Brain Dev 2010; 1: 71-7.
• 48. Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992; 6: 163-8.
• 49. Dulac O, Plouin P, Shewmon A. Myoclonus and epilepsy in childhood: 1996 Royaumont meeting. Epilepsy Res 1998; 30: 91-106.
• 50. Panayiotopoulos CP, Ferrie CD, Knott C, et al. Interaction of lamotrigine with sodium valproate. Lancet 1993; 341: 445.
• 51. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002; 33: 122-32.
• 52. Yamatogi Y, Ohtahara S. Multiple independent spike foci and epilepsy, with special reference to a new epileptic syndrome of "severe epilepsy with multiple independent spike foci". Epilepsy Res 2006; 70: 96-104.
• 53. Yamatogi Y, Ohtahara S. Severe epilepsy with multiple independent spike foci. J Clin Neurophysiol 2003; 20: 442-8.